• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD
Global Synthetic Biology Market 2014-2018 - Product Image

Global Synthetic Biology Market 2014-2018

  • ID: 2890999
  • July 2014
  • Region: Global
  • 74 pages
  • TechNavio

FEATURED COMPANIES

  • Algenol Biofuels Inc.
  • Bayer AG
  • Cobalt Technologies
  • GeneWorks Pty Ltd.
  • Ginkgo Bioworks
  • OriGene Technologies Inc.
  • MORE

About Synthetic Biology

The term synthetic biology covers the designing and engineering of completely new biological parts, devices, and organisms as well as the redesigning of natural biological systems that provide improved and desirable functions. It is considered to be a form of extreme genetic engineering because it not only alters existing metabolic pathways, but also creates new ones. The engineered biological systems can be used to manipulate chemicals, fabricate materials and structures, produce energy, provide GM food, improve the efficiency of drugs and vaccines, and maintain a sustainable environment.

The analysts forecast the Global Synthetic Biology market will grow at a CAGR of 33.8 percent over the period 2013-2018.

Covered in this Report
The Global Synthetic Biology market can be categorized on the basis of technology into four segments: Genome Engineering. DNA Sequencing, Bioinformatics, and Biological Components and Integrated Systems.

The report, the Global Synthetic Biology Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas and the EMEA and APAC READ MORE >

FEATURED COMPANIES

  • Algenol Biofuels Inc.
  • Bayer AG
  • Cobalt Technologies
  • GeneWorks Pty Ltd.
  • Ginkgo Bioworks
  • OriGene Technologies Inc.
  • MORE

01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview
03.2 Product and Service Offerings
04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05. Introduction
06. Market Landscape
06.1 Market Overview
06.2 Market Size and Forecast
06.3 Five Forces Analysis
07. Market Segmentation by Technology
08. Market Segmentation by Product
09. Market Segmentation by Applications
10. Geographical Segmentation
10.1 Synthetic Biology Market in the Americas
10.1.1 Market Size and Forecast
10.2 Synthetic Biology Market in the EMEA Region
10.2.1 Market Size and Forecast
10.3 Synthetic Biology Market in the APAC Region
10.3.1 Market Size and Forecast
11. Buying Criteria
12. Market Growth Drivers
13. Drivers and their Impact
14. Market Challenges
15. Impact of Drivers and Challenges
16. Market Trends
17. Trends and their Impact
18. Vendor Landscape
18.1 Competitive Scenario
18.1.1 Key News
18.1.2 Mergers and Acquisitions
18.2 Vendor Share Analysis 2013
18.3 Other Prominent Vendors
19. Key Vendor Analysis
19.1 Amyris Inc.
19.1.1 Key Facts
19.1.2 Business Description
19.1.3 Business Strategy
19.1.4 Geographical Segmentation
19.1.5 Key Developments
19.1.6 SWOT Analysis
19.1.7 Strengths
19.1.8 Weakness
19.1.9 Opportunities
19.1.10 Threats
19.2 E. I. du Pont de Nemours and Company
19.2.1 Key Facts
19.2.2 Business Description
19.2.3 Business Segmentation
19.2.4 Business Strategy
19.2.5 Revenue Segmentation
19.2.6 Revenue Comparison 2013-2011
19.2.7 Geographical Segmentation
19.2.8 Key Developments
19.2.9 SWOT Analysis
19.2.10 Strengths
19.2.11 Weakness
19.2.12 Opportunities
19.2.13 Threats
19.3 Synthetic Genomics, Inc.
19.3.1 Key Facts
19.3.2 Business Overview/ Description
19.3.3 Business Strategy
19.3.4 Key Information
19.3.5 SWOT Analysis
19.3.6 Strengths
19.3.7 Weakness
19.3.8 Opportunities
19.3.9 Threats
19.4 Thermo Fisher Scientific Inc.
19.4.1 Key Facts
19.4.2 Business Overview
19.4.3 Business Segmentation
19.4.4 Revenue Segmentation by Business
19.4.5 Revenue Segmentation by Products
19.4.6 Sales by Geographical Segmentation
19.4.7 Business Strategy
19.4.8 Key Information
19.4.9 SWOT Analysis
19.4.10 Strengths
19.4.11 Weaknesses
19.4.12 Opportunities
19.4.13 Threats
20. Other Reports in this Series

List of Exhibits
Exhibit 1: Market Research Methodology
Exhibit 2: Global Synthetic Biology Market 2013-2018 (US$ million)
Exhibit 3: Global Synthetic Biology Market Segmentation by Technology
Exhibit 4: Global Synthetic Biology Market Segmentation by Technology 2013
Exhibit 5: Global Synthetic Biology Market Segmentation by Product
Exhibit 6: Global Synthetic Biology Market Segmentation by Applications
Exhibit 7: Global Synthetic Biology Market Segmentation by Applications 2013
Exhibit 8: Global Synthetic Biology Market by Geographical Segmentation 2013
Exhibit 9: Synthetic Biology Market in the Americas 2013-2018 (US$ million)
Exhibit 10: Synthetic Biology Market in the EMEA Region 2013-2018 (US$ million)
Exhibit 11: Synthetic Biology Market in the APAC Region 2013-2018 (US$ million)
Exhibit 12: Number of Entities Conducting Research in the Global Synthetic Biology Market 2013
Exhibit 13: Amyris Inc.: Segmentation by Geography 2013
Exhibit 14: Amyris Inc.: Revenue Comparison by Geographical Segmentation 2013-2011 (US$ million)
Exhibit 15: Business Segmentation of DuPont: 2013
Exhibit 16: Revenue Segmentation of DuPont 2013
Exhibit 17: DuPont:Revenue Comparison by business segments for 2013-2011(US$ million)
Exhibit 18: DuPont by Geographical Segmentation 2013
Exhibit 19: DuPont Revenue Comparison by Geography segments for 2013-2011 (US$ million)
Exhibit 20: Business Segmentation of Thermo Fisher Scientific Inc.
Exhibit 21: Revenue by Business Segments of Thermo Fisher Scientific Inc. 2013
Exhibit 22: Revenue by Products of Thermo Fisher Scientific Inc. 2013
Exhibit 23: Sales by Geographical Segmentation of Thermo Fisher Scientific Inc. 2013

FEATURED COMPANIES

  • Algenol Biofuels Inc.
  • Bayer AG
  • Cobalt Technologies
  • GeneWorks Pty Ltd.
  • Ginkgo Bioworks
  • OriGene Technologies Inc.
  • MORE

Commenting on the report, an analyst from the team said: “There is growing demand for GM crops in the Agriculture industry across the world. Synthetic biology can also be used to develop crops with desirable traits such as salt-tolerance, drought-tolerance, and pest-resistance. The use of synthetic biology technologies facilitates the designing of GM crops with entirely new metabolic pathways, physiological traits, and developmental control strategies. The need to improve crops is now increasing as plants are not only considered as food, but also as a source of renewable feedstocks. This trend is expected to increase growth in the Global Synthetic Biology market over the forecast period ”

According to the report, the growth of the Global Synthetic Biology market is driven by several factors. One of the main drivers in this market is increased R&D in synthetic biology. As synthetic biology enables the development of innovative products through gene manipulation, vendors and various other research organizations are increasingly investing in R&D, so that they can offer new products in the market.

Further, the report states that one of the major challenges in the market is the lack of modularized biological parts. Lack of standardization and modularization of synthesized biological parts causes unpredictability in their function that poses a risk of the crash of the biological circuitry. Other major challenges in the market are ethical, biosafety, and biosecurity concerns.

The report also includes a discussion of the other vendors operating in this market. The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

- Amyris Inc.
- E. I. du Pont de Nemours and Co.
- Thermo Fisher Scientific Inc.
- Synthetic Genomics Inc.
- Algenol Biofuels Inc.
- ATG:biosynthetics GmbH
- Bayer AG
- Bioneer Corp.
- Biosearch Technologies Inc.
- Bristol-Myers Squibb Co.
- CBC Comprehensive Biomarker Center GmbH
- Cobalt Technologies
- Evolva Holdings SA
- Exxon Mobil Corp.
- GeneWorks Pty Ltd.
- Genomatica Inc.
- Gevo Inc.
- Ginkgo Bioworks
- Green Biologics Ltd.
- New England Biolabs Inc.
- OriGene Technologies Inc.
- REG Life Sciences LLC
- Royal DSM
- Synthorx Inc.

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos